ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
184 hedge funds and large institutions have $761M invested in Acorda Therapeutics in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 79 increasing their positions, 41 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
52% less call options, than puts
Call options by funds: $2.4M | Put options by funds: $5.05M
Holders
184
Holding in Top 10
–
Calls
$2.4M
Puts
$5.05M
Top Buyers
| 1 | +$24.2M | |
| 2 | +$10.2M | |
| 3 | +$8.5M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$5.36M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$4.5M |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$15.2M | |
| 3 | -$13.7M | |
| 4 |
Millennium Management
New York
|
-$9.7M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.79M |